// App-Quantinova.ai

8010 : Response status as predictor of survival after autologous hematopoietic cell transplant (AHCT), without or with consolidation (with bortezomib, lenalidomide (Len) and dexamethasone) and len maintenance (AM vs. ACM) versus tandem AHCT and len maintenance (TAM) for up-front treatment of patients (pts) with multiple myeloma (MM): BMT CTN0702-stamina (NCT01109004).

Researchers

Presenter

  • George Somlo

Principal Investigators

  • Beth Blackwell

  • Steven Michael Devine

  • Siddhartha Ganguly

  • Yvonne Efebera

  • Sergio Giralt

  • Parameswaran Hari

  • John Koreth

  • Heather Jolie Landau

  • Brian L. McClune

  • Mussafar Quazilbash

  • Philip L. McCarthy

  • Nina Shah

  • David H. Vesole

  • Ravi Vij

  • Dan T. Vogl

  • Amrita Y. Krishnan

  • Edward A. Stadtmauer

  • Nancy Geller

Medical Centers

  • City of Hope, Duarte, CA

  • The Medical College of Wisconsin, Milwaukee, WI

  • EMMES, Milwaukee, WI

  • The Ohio State University Comprehensive Cancer Center, Columbus, OH

  • Kansas University Medical Center, Kansas City, KS

  • The Ohio State Univerisity, Columbus, OH

  • Memorial Sloan Kettering Cancer Center, Port Washington, NY

  • Dana-Farber Cancer Institute, Boston, MA

  • University of Minnesota, Minneapolis, MN

  • The University of Texas MD Anderson Cancer Canter, Houston, TX

  • Roswell Park Cancer Institute, Buffalo, NY

  • John Theurer Cancer Centre, Hackensack University Medical Center, Hackensack, NJ

  • Washington University School of Medicine, St. Louis, MO

  • Abramson Cancer Center, Philadelphia, PA

  • The National Heart Lung and Blood Institute, the National Institute of Health, North Bethesda, MD

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • N/A

Biomarkers

  • Stromal interaction molecule 1

Drug/Treatment

  • Dexamethasone

  • Dekpak 13 Day Taperpak

  • Lenalidomide

  • Bortezomib

  • Melphalan

Outcome

  • N/A

Study Design

  • Randomized

Phase

  • NA

Study Id's

  • NCT01109004

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved